Related references
Note: Only part of the references are listed.National Estimates of Financial Hardship From Medical Bills and Cost-related Medication Nonadherence in Patients With Inflammatory Bowel Diseases in the United States
Nghia H. Nguyen et al.
INFLAMMATORY BOWEL DISEASES (2021)
The Cost of Inflammatory Bowel Disease: An Initiative From the Crohn's & Colitis Foundation
K. T. Park et al.
INFLAMMATORY BOWEL DISEASES (2020)
Management of Inflammatory Bowel Diseases in Special Populations: Obese, Old, or Obstetric
Siddharth Singh et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2020)
Longitudinal Trends in the Direct Costs and Health Care Utilization Ascribable to Inflammatory Bowel Disease in the Biologic Era: Results From a Canadian Population-Based Analysis
Laura E. Targownik et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2020)
Assessing National Trends and Disparities in Ambulatory, Emergency Department, and Inpatient Visits for Inflammatory Bowel Disease in the United States (2005-2016)
Christopher Ma et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2020)
US Health Care Spending by Payer and Health Condition, 1996-2016
Joseph L. Dieleman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017
Sudabeh Alatab et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2020)
Cost-effectiveness of Telemedicine-directed Specialized vs Standard Care for Patients With Inflammatory Bowel Diseases in a Randomized Trial
Marin J. de Jong et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2020)
Integration of telemedicine into clinical practice for inflammatory bowel disease
Lauren A. George et al.
CURRENT OPINION IN GASTROENTEROLOGY (2020)
Declining hospitalisation and surgical intervention rates in patients with Crohn's disease: a population-based cohort
Adam Rahman et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2019)
A Randomized Controlled Trial of TELEmedicine for Patients with Inflammatory Bowel Disease (TELE-IBD)
Raymond K. Cross et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2019)
Burden and Cost of Gastrointestinal, Liver, and Pancreatic Diseases in the United States: Update 2018
Anne F. Peery et al.
GASTROENTEROLOGY (2019)
Past and Future Burden of Inflammatory Bowel Diseases Based on Modeling of Population-Based Data
Stephanie Coward et al.
GASTROENTEROLOGY (2019)
Population Health Management for Inflammatory Bowel Disease
Parambir S. Dulai et al.
GASTROENTEROLOGY (2018)
Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017
Spencer L. G. James et al.
LANCET (2018)
Market share and costs of biologic therapies for inflammatory bowel disease in the USA
H. Yu et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
Factors Associated With Increases in US Health Care Spending, 1996-2013
Joseph L. Dieleman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Surgical Rates for Crohn's Disease are Decreasing: A Population-Based Time Trend Analysis and Validation Study
Christopher Ma et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2017)
Health Insurance Paid Costs and Drivers of Costs for Patients With Crohn's Disease in the United States
K. T. Park et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2016)
Prevalence of Inflammatory Bowel Disease Among Adults Aged ≥18 Years - United States, 2015
James M. Dahlhamer et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2016)
Healthcare costs of inflammatory bowel disease have shifted from hospitalisation and surgery towards anti-TNF alpha therapy: results from the COIN study
Mirthe Emilie van der Valk et al.
GUT (2014)
Clinical and economic outcomes in a population-based European cohort of 948 ulcerative colitis and Crohn's disease patients by Markov analysis
S. Odes et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2010)
Share Paper
